Polymerase theta repair may extend life by sealing persistent genetic breaks with mutations
In old organisms, brief polymerase theta activity may seal persistent DNA (deoxyribonucleic acid) breaks, reducing inflammatory secretion and extending remaining life despite added mutations. Lasting benefit without new DNA junctions would refute the mechanism.
Stage of verification
- Hypothesis published2026-09-30
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Ageing mechanism
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.
Enzyme
DNA polymerase theta
An enzyme that participates in joining broken DNA ends
Where this hypothesis actsLong-lived cells with persistent DNA breaks that sustain inflammatory secretion in an old organism
Hypotheses on this target 1
Inhibition
Activation
Lower level
Higher level1
Replacement
Protection from degradation
Cofactor removal
Synthesis suppression
Function preservation
What is proposed
Higher level
Briefly increase polymerase-mediated joining of broken DNA ends
With whatControlled genetic model
HowInducible polymerase expression for cellular testing; targeted closure of persistent breaks in an old organism remains technically unresolved
Possible result
Possible lasting reduction in damage transmission and longer remaining life despite increased insertions and deletions
From the recordПредполагается, что краткое усиление соединения концов ДНК с участием полимеразы тета превращает часть таких разрывов в закрытые участки с небольшими вставками и делециями.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
An old body's damaged cells might keep harming other tissues because some genetic breaks remain open. The unexpected move is to accept new errors in the genetic instructions as the price of closing those breaks and stopping their continuing effects. This is a hypothesis generated by the pipeline, not a measured extension of life.
- Persistent DNA breaks in long-lived cells sustain the release of substances that promote inflammation.
- A brief increase in polymerase theta joins some broken DNA ends while adding or deleting small pieces of sequence.
- Open breaks become closed DNA with altered instructions, and the closed state persists after the intervention stops.
- Closing the breaks reduces the continuing inflammatory output attributed to them.
- Reduced inflammatory output lessens damage to blood vessels, muscles and liver.
- Less damage returning from other systems reduces renewed break formation, helping the lower-damage state persist.
- The benefit of interrupting continuing damage outweighs the consequences of the new sequence errors and extends remaining life.
A leaking pipe can be patched with an imperfect repair that leaves a permanent flaw but stops water from damaging the surrounding rooms.
Where the picture breaks: DNA carries instructions, so an imperfect join can change how a cell behaves. A closed break therefore cannot be assumed harmless, and the picture does not establish that stopping one source of damage makes the whole organism live longer.
- Master questionstep 01 of 04
Aging processes may strengthen one another, making a shared cause a possible target for improving several body systems at once.
Rests on: The goal is to generate life-extension ideas that interrupt a shared cause of damage across systems.
AssumptionThe starting premise is that mutually reinforcing aging processes may share a causal link whose alteration benefits several systems. The supplied material does not establish a particular shared link at this stage.
- Goal pillarstep 02 of 04
The desired output is a collection of life-extension ideas that work through distinct causes.
Rests on: The master question explicitly requests ideas for targeting shared causes of aging.
Stated in the chain - Gap questionstep 03 of 04
A brief intervention might leave much existing damage in place yet stop systems from reinforcing one another's damage after treatment ends. The proposed switch is from damage growing through repeated exchanges to damage diminishing through those exchanges.
Rests on: The search for shared causal targets is narrowed to targets that could produce a lasting change after a temporary intervention. A mathematical model of damage transfer supplies the proposed dividing point between amplification and damping.
AssumptionThe question assumes that damage transfer can be represented by a matrix, a table of effects between systems, with a stability boundary at an amplification factor of 1. No measurements or fitted model establish that description for an old organism, or that changing one link would cross its boundary.
- Hypothesisstep 04 of 04
Persistent DNA breaks are proposed to make long-lived cells continually release substances that promote inflammation. Briefly increasing polymerase theta could close some breaks while adding or removing small pieces of DNA sequence. Those lasting joins are proposed to reduce damage to blood vessels, muscles and liver enough to extend remaining life, even though many earlier defects remain and new sequence errors accumulate.S3S6
Rests on: The previous question supplies the idea of a brief intervention leaving a durable change without removing most damage. Two biological links have literature support: persistent breaks can contribute to inflammatory release, and polymerase theta can join broken DNA with sequence errors. EMBO reports (2020), S3, connects persistent breaks to the development of inflammatory release by cells, but does not test this repair intervention or lifespan. DNA repair (2016), S6, describes polymerase theta joining broken ends and adding sequence at joins, but does not establish lasting closure, reduced inflammation or longer life in old organisms.
Supported by literature
What is carried, and what is not. Screened sources speak to two of the seven proposed links: persistent breaks contributing to inflammatory release, and polymerase theta joining DNA with sequence errors, within the limits described above. No supplied source establishes the sequence from a temporary intervention through lasting repair and reduced damage between systems to longer remaining life, or shows that it crosses the proposed mathematical stability boundary.
Where the reasoning is carried by something unstated · 2
- Master question. The starting premise is that mutually reinforcing aging processes may share a causal link whose alteration benefits several systems. The supplied material does not establish a particular shared link at this stage.
- Gap question. The question assumes that damage transfer can be represented by a matrix, a table of effects between systems, with a stability boundary at an amplification factor of 1. No measurements or fitted model establish that description for an old organism, or that changing one link would cross its boundary.
How a result here could mislead · 3
- Lower inflammation and fewer measured breaks could be credited to repair even if damaged cells died and disappeared from the measurements. That would confuse repairing cells with removing them. What closes it: Break measurements and sequencing, the reading of DNA's letter order, must be interpreted alongside cell survival and cell loss in the affected tissues. The proposed survival study explicitly calls for accounting for cell death, but the supplied specification does not establish a method for distinguishing these explanations.
- A benefit lasting after treatment withdrawal could be called a durable consequence of new DNA joins while the intervention remains active, or while inflammation is merely being suppressed. Persistence alone would also fail to separate this proposal from the supplied rivals involving tissue arrangement, infection or damaged proteins. What closes it: The proposed observations at 1, 3 and 6 months require confirmed cessation of intervention activity and joint measurement of new joins, physical breaks and damage transfer between systems. The design also specifies a polymerase unable to perform its joining reaction and a brief inflammation-suppression comparison with similar early functional improvement; neither persistence nor improved function alone identifies the proposed cause.
- More closed breaks and better organ function could be read as beneficial repair even if some joins connect different chromosomes, the separate DNA packages in cells, or if later tumors erase the early benefit. What closes it: The specification requires separate analysis of breaks at telomeres, the protective ends of chromosomes, because joining different chromosome ends can create dangerous rearrangements. Remaining lifespan must be measured with tumors and cell death accounted for; lower inflammation and early functional improvement are insufficient.
What would make this wrong. Lasting benefit without new DNA joins would contradict the proposed mechanism, as the hypothesis explicitly states. If verified closure of the targeted persistent breaks failed to reduce inflammatory release and damage transfer, the central causal sequence would also fail. Durable organ improvement without longer remaining life would fail the bold life-extension claim. Conversely, a negative result without verified closure would leave failure of the intervention unresolved. The supplied material defines neither its named damage score nor a quantitative criterion for sufficient closure or reduced damage transfer.
What it would change. If the full prediction held, a shared life-extension target could be a continuing source of damage whose shutdown matters more than reducing the total number of genetic errors. Work pursuing the master question would then need to distinguish lasting interruption of damage exchange from removal of accumulated damage. Even a successful result would establish benefit only in the tested organism and conditions; it would not by itself establish benefit in humans or prove that the proposed mathematical stability boundary had been crossed.
Sources read · 9
cGAS/STING Pathway Mediates Accelerated Intestinal Cell Senescence and SASP After GCR Exposure in Mice. · Cells · 2025
“GCRsim induced sustained DNA double-strand breaks (DSBs) and oxidative stress, as shown by elevated γH2AX foci and 4-HNE staining. Intestinal epithelial cells (IECs) exhibited pronounced senescence, marked by increased SA-β-gal activity, p16 upregulation, LaminB1 loss, and induction of senescence-associated secretory phenotype (SASP) cytokines”
Does not settle: Источник описывает облучённых мышей и кишечный эпителий через 5 месяцев. Он не исследует полимеразу тета, намеренное усиление соединения концов ДНК, возникающие мутации, закрытие разрывов, сосуды, мышцы, печень или продолжительность жизни организма.
Mangiferin protects mesenchymal stem cells against DNA damage and cellular aging via SIRT1 activation. · Mechanisms of ageing and development · 2025
“MAG and metformin treatment enhanced cell proliferation, reduced senescence-associated β-galactosidase staining, and lowered the levels of the senescence-associated secretory phenotype factors IL-1A, IL-1B, IL-6, IL-8, CCL2, and CCL20 and senescence marker CDKN1A, CDKN2A and p53.”
Does not settle: This abstract does not test polymerase theta, mutagenic end joining, persistent unrepaired breaks, lasting DNA closure after treatment, or remaining lifespan in old organisms.
Non-canonical ATM/MRN activities temporally define the senescence secretory program. · EMBO reports · 2020
“Senescence‐inducing persistent DNA double‐strand breaks ( pDSB s) cause an immediate DNA damage response ( DDR ) and SAPA , but the SASP requires days to develop.”
Does not settle: Источник связывает стойкие двунитевые разрывы ДНК с ответом на повреждение и описывает созревание секреторного фенотипа клеточного старения. Он не изучает полимеразу тета, соединение концов ДНК, возникающие вставки и делеции, сосуды, мышцы или печень, снижение воспалительной секреции после вмешательства, а также продолжительность жизни старого организма.
Neurons burdened by DNA double-strand breaks incite microglia activation through antiviral-like signaling in neurodegeneration. · Science advances · 2022
“In conclusion, DSBs activate immune pathways in neurons, which in turn adopt a senescence-associated secretory phenotype to elicit microglia activation.”
Does not settle: Источник описывает нейроны с двунитевыми разрывами ДНК в модели нейродегенерации у мышей и не проверяет усиление репарации с участием полимеразы тета, вызванные ею мутации, закрытие разрывов, последствия для сосудов, мышц или печени, а также продолжительность жизни старого организма.
XRCC1 promotes replication restart, nascent fork degradation and mutagenic DNA repair in BRCA2-deficient cells. · NAR cancer · 2020
“While this pathway is mutagenic and presumably contributes to genomic instability by generating deletions with microhomologies at the breakpoints to enable replication restart at microhomologies, it would enable HR-deficient cancer cells to complete replication”
Does not settle: Источник описывает путь при репликационном стрессе в BRCA2-дефицитных раковых клетках. Он не устанавливает, что краткое усиление полимеразы тета закрывает стойкие разрывы в долгоживущих клетках старого организма, снижает воспалительную секрецию или продлевает жизнь.
DNA polymerase θ (POLQ), double-strand break repair, and cancer. · DNA repair · 2016
“Pol θ is able to mediate joining of two resected 3’ ends harboring DNA sequence microhomology. “Signatures” of Pol θ action during altEJ are the frequent utilization of longer microhomologies, and the insertion of additional sequences at joining sites.”
Does not settle: Источник не устанавливает, что кратковременное усиление POLQ закрывает персистирующие разрывы в долгоживущих клетках старого организма, снижает воспалительную секрецию или SPV_1, либо продлевает оставшуюся жизнь. Не приведены данные о вмешательстве, дозе, длительности, тканях сосудов, мышц или печени и соотношении пользы с последствиями новых мутаций.
Polymerase theta: Genome protection through regulated deployment. · DNA repair · 2026
“DNA Polymerase theta (Polθ, gene name POLQ) is the central enzyme of theta-mediated end-joining (TMEJ), an intrinsically mutagenic DNA double-strand break (DSB) repair pathway.”
Does not settle: Источник не устанавливает, что кратковременное усиление Polθ закрывает стойкие разрывы у старых организмов, снижает воспалительную секрецию или продлевает оставшуюся жизнь. Он также не сообщает о тканях, дозе, длительности воздействия, последствиях соматических мутаций и устойчивости эффекта после прекращения воздействия.
To indel or not to indel: Factors influencing mutagenesis during chromosomal break end joining. · DNA repair · 2022
“In contrast, repair of DSBs leading to deletion mutations using extensive microhomology are largely independent of C-NHEJ, and are promoted by DNA polymerase theta (Polθ/POLQ).”
Does not settle: Источник описывает механизмы соединения концов разрывов ДНК в клетках млекопитающих. Он не устанавливает, что незавершённые разрывы поддерживают воспалительную секрецию в долгоживущих клетках, что усиление POLQ может безопасно закрывать такие разрывы у старого организма, или что возникающие мутации продлевают оставшуюся жизнь и улучшают состояние сосудов, мышц либо печени.
Therapeutic targeting of DNA repair pathway dysregulation in aging, cancer, and neurodegeneration. · Expert opinion on therapeutic targets · 2026
“We discuss how oxidative stress, replication stress, telomere dysfunction, mitochondrial injury, and persistent DNA damage response signaling drive senescence and inflammation;”
Does not settle: It does not establish that POLQ-mediated end joining closes persistent breaks in long-lived cells, causes beneficial somatic mutations, reduces inflammation in old organisms, or extends remaining lifespan.
The gap this hypothesis explains
Nothing is known here: the question has not been asked of this system.
Can briefly changing one damage-spreading link durably stop aging processes from reinforcing each other while substantial damage remains?
Original wording · exactly as the pipeline generated it
Может ли краткая коррекция одного звена надолго остановить взаимное усиление старения после отмены, если она переводит матрицу межсистемной передачи повреждений через порог устойчивости ρ(A)=1, оставляя значительную часть исходных повреждений?
What this question is asking
The question concerns whether a temporary intervention can leave the body's interacting systems on a persistently less damaging course. It asks whether changing one causal link between those systems can stop their mutual reinforcement after treatment ends, even while much of the original damage remains. The proposed explanation assumes that damage transmission can be represented by a mathematical matrix and that treatment moves it across a boundary separating amplification from decay. The relevant comparison is with the course without that temporary correction, assessing whether reduced damage amplification and slower functional decline persist for months after withdrawal, alongside survival follow-up.
- Damage-spreading link or causal connection
- An influence through which a harmful change in one body system produces a harmful change in another. The question leaves the particular connection unspecified; a causal connection means more than two systems changing together.
- Feedback loop and mutual amplification
- A chain in which a change feeds back to influence its own starting point. In a damaging, self-reinforcing loop, one system worsens another, which then worsens the first.
- Damage-transmission matrix A
- A mathematical table intended to represent how strongly damage in each system affects damage in other systems. Here it is a proposed representation, not a measurement established by the supplied sources.
- Spectral radius ρ(A) and stability boundary
- The spectral radius is the largest absolute size of a matrix's eigenvalues, numbers describing how the matrix scales characteristic patterns of change. In a model that repeatedly applies the same matrix, a value below one makes existing disturbances decay, while a value above one permits amplification. Applying that boundary to an aging body requires assumptions that the supplied sources do not establish.
- Finite treatment course and withdrawal
- A finite course has an endpoint, and withdrawal means stopping the intervention. The question concerns effects that continue after this endpoint, rather than improvement measured only during treatment.
- Functional decline and survival follow-up
- Functional decline means worsening ability of organs or the body to perform their tasks. Survival follow-up tracks whether and how long study subjects remain alive; it is a different outcome from improvement in a particular abnormality.
- Hepatocyte-specific growth hormone receptor ablation
- Hepatocytes are liver cells, and a growth hormone receptor is a cell component that receives a growth-hormone signal. Ablation here means experimental removal of that receptor specifically from these cells, creating the particular mouse system studied in S1.
- Pyruvate dehydrogenase kinase 4 inhibition
- Pyruvate dehydrogenase kinase 4 is an enzyme involved in regulating how cells process fuel. Inhibition means reducing its activity; S1 reports using a drug to do so in living mice.
- Lung–kidney axis
- A collective name for interactions between the lungs and kidneys, rather than a separate anatomical structure or a single connection. S2 describes how damaging changes can travel in both directions within these interactions.
- Thymus and adaptive immunity
- The thymus is an organ involved in developing immune cells used in adaptive immunity, the body's capacity for targeted responses to particular threats. S4 connects deterioration of this organ with weakened immune function and aging elsewhere in the body.
- Oxidative stress
- A state in which reactive oxygen-related chemicals exceed the capacity to control their effects and can damage cell components. S6 discusses it as a possible starting point for persistent changes.
- Epigenetic changes
- Changes in how genetic information is used without changing the underlying genetic sequence. This is a class of regulatory changes; S6 discusses them as a possible route by which earlier stress leaves lasting effects.
- Mitochondrial dysfunction
- Impaired operation of mitochondria, cell structures involved in energy conversion and other cellular processes. S6 discusses this as another possible contributor to lasting effects of stress.
- Metabolic memory
- A term for persistent effects of an earlier disturbance in the body's processing of energy and materials. It names a pattern of lasting influence, not a single established storage mechanism.
- Biological aging
- Age-related changes in the condition and functioning of the body, rather than simply elapsed years. The supplied S6 quotation discusses possible acceleration of this process without supplying a particular measurement.
Aging processes mutually reinforce through a damage-transmission matrix whose stability boundary is ρ(A)=1, and correcting one causal link can cross that boundary while substantial original damage remains.
The assumption concerns organs and body systems passing harmful effects back and forth. It proposes that a table of the strengths of those effects has a calculable boundary between increasing and fading damage, and that changing one connection can move the whole body across it without removing much existing damage. If established, this would supply a reason why a short intervention might have lasting effects.
S2 describes a damaging feedback loop between lungs and kidneys, and S4 describes a self-reinforcing relationship between deterioration of the thymus and aging elsewhere in the body. These support the narrower premise that reciprocal harmful interactions occur. The supplied evidence does not establish an organism-wide damage-transmission matrix, the applicability of ρ(A)=1 as its biological stability boundary, or a one-link intervention that crosses that boundary while leaving substantial damage. This lack of support does not establish that the proposed mechanism is false.S2S4
The same question asked without the part nothing read establishes:
- Can a brief intervention on one damage-spreading link durably reduce mutual worsening between body systems after withdrawal, while substantial damage remains?
- Does improvement from temporarily changing one aging-related interaction persist after treatment ends and extend to body function and survival?
- Mutual amplification remains suppressed after withdrawal Under the proposed mechanism, changing one connection would leave successive rounds of damage transmission weaker even after treatment ends. This would support lasting benefit from a finite course, but remaining damage could still limit function; stopping amplification would not itself establish recovery or longer survival.
- Mutual amplification resumes after withdrawal The intervention would weaken the damaging interaction only temporarily, with the remaining damage again feeding the loop once treatment stops. Improvement during treatment would therefore not establish that a finite course produces a lasting change.
- A local problem improves without stopping mutual amplification Changing the targeted link would improve a particular outcome while other damaging interactions continue. That result would support a limited benefit without establishing the proposed transition in the behavior of the whole body.
If damage in one organ worsens another organ, and that organ sends damaging effects back, an initial problem can become self-reinforcing; the lung–kidney review describes such a loop [S2]. Reducing one connecting influence could, in the question's proposed mechanism, weaken successive rounds of damage. Lasting benefit would require that weakening to persist after the intervention ends, despite the damage still present. Mistaking improvement during treatment for a lasting interruption would overstate what a finite course achieves, while equating reduced amplification with repaired damage would overstate recovery.
Узлы RL-1 и RL-2 описывают обратные связи, память и замедленное восстановление; управляемый переход устойчивости целого организма не установлен.
Устойчивое снижение межсистемного усиления и функционального ухудшения после конечного курса; сохранение эффекта проверяется месяцами и исследованием выживаемости.
Неизвестно, достаточно ли изменения одной причинной связи для длительного затухания повреждений после отмены воздействия.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Длительное межсистемное усиление повреждения поддерживают незавершённые разрывы ДНК в долгоживущих клетках, постоянно вызывающие воспалительную секрецию. Предполагается, что краткое усиление соединения концов ДНК с участием полимеразы тета превращает часть таких разрывов в закрытые участки с небольшими вставками и делециями. После прекращения воздействия сохраняется химически завершённая структура ДНК. Смелая версия гипотезы утверждает, что намеренное увеличение числа таких соматических мутаций способно продлить оставшуюся жизнь старого организма: прекращение непрерывного повреждающего воздействия на сосуды, мышцы и печень перевешивает последствия новых ошибок последовательности. Значительная часть исходных мутаций, белковых повреждений и изменений матрикса сохраняется. Уменьшение повторного образования разрывов под действием соседних систем закрепляет снижение SPV_1.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
Через 1, 3 и 6 месяцев после подтверждённого прекращения активности вмешательства сохраняются новые участки соединения ДНК, уменьшается число физических разрывов и ослабевает передача повреждения между системами. При этом число вставок и делеций увеличивается. Каталитически неактивная полимераза эффекта не даёт. Краткое подавление воспалительной секреции с сопоставимым ранним улучшением функций уступает по длительности пользы. Решающий результат: улучшение сосудистой реактивности, мышечной функции и функции печени вместе с увеличением оставшейся продолжительности жизни при возросшей мутационной нагрузке. Сохранение пользы при отсутствии новых соединений ДНК опровергает предложенный механизм.
States a measurable outcome; comparing rivals needs more conditions. The prediction specifies timed outcomes, directional changes, control comparisons, and an explicit rejection condition. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Клеточную проверку позволяют провести индуцируемая экспрессия полимеразы, измерение разрывов и секвенирование участков соединения. Адресное закрытие естественных стойких разрывов в старом организме остаётся технической задачей. Теломерные разрывы следует анализировать отдельно: соединение концов разных хромосом способно создавать опасные перестройки. Исследование выживаемости должно учитывать опухоли и гибель клеток, иначе снижение воспалительных показателей будет недостаточным результатом.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
Через 1, 3 и 6 месяцев после подтверждённого прекращения активности вмешательства сохраняются новые участки соединения ДНК, уменьшается число физических разрывов и ослабевает передача повреждения между системами. При этом число вставок и делеций увеличивается. Каталитически неактивная полимераза эффекта не даёт. Краткое подавление воспалительной секреции с сопоставимым ранним улучшением функций уступает по длительности пользы. Решающий результат: улучшение сосудистой реактивности, мышечной функции и функции печени вместе с увеличением оставшейся продолжительности жизни при возросшей мутационной нагрузке. Сохранение пользы при отсутствии новых соединений ДНК опровергает предложенный механизм.
- Rival 01 of 03What would separate them
Briefly lowering cell surface tension may let cells swap neighbors and durably ease tissue stress predicts: Короткое воздействие даёт длительную пользу только в участках, где произошли обмены клеточными соседями. При одинаковом снижении кортикального натяжения геометрическое ограничение перестановок устраняет последующий устойчивый эффект. После отмены воздействия натяжение возвращается к исходному уровню, но новая карта соседств и уменьшенное остаточное напряжение сохраняются. Число мутаций, вирусная нагрузка и распределение белков между растворимой фракцией и включениями могут остаться прежними. Воспроизведение исходной геометрии в тканевой модели возвращает повреждающую секрецию. Длительная польза при неизменной карте соседств опровергает эту гипотезу.
- What would separate them
Destroying latent viral genomes may reduce recurring damage across organ systems predicts: После подтверждённого прекращения активности противовирусного вмешательства длительное улучшение появляется преимущественно у животных с исходной латентной инфекцией и зависит от утраты способности вируса реактивироваться. В свободной от исследуемой инфекции группе сопоставимого эффекта нет. Ответ на одинаковое стерильное возмущение и оценённые коэффициенты A остаются близкими к исходным, тогда как число спонтанных эпизодов ухудшения уменьшается. Восстановление инфекции возвращает эти эпизоды. Длительная польза у свободных от инфекции животных при сохранении способности вируса реактивироваться в инфицированной группе опровергает предложенное объяснение.
- Rival 03 of 03Trapping misfolded proteins in lasting inclusions may reduce damage across organs
Not yet published.
What would separate themTrapping misfolded proteins in lasting inclusions may reduce damage across organs predicts: После отмены воздействия уменьшается растворимая токсичная фракция, увеличивается доля белка во включениях и сохраняется функциональная польза. Метка исходного белкового груза подтверждает его длительное удержание. Избирательное высвобождение того же груза из включений возвращает повреждающий эффект при сопоставимой общей массе белка; контроль самого воздействия исключает повреждение от процедуры высвобождения. Устойчивое улучшение при полном предотвращении образования включений опровергает механизм. Гипотеза также предсказывает возможную потерю пользы, если последующая нагрузка вызывает распад включений.
Why this is not the mainstream account
The engine is asked to say what its hypothesis would overturn and what would surprise a specialist. This is its answer.
Fumagalli и соавторы показали длительное сохранение ответа на теломерные повреждения; Kent и соавторы установили способность полимеразы тета соединять разорванные молекулы посредством коротких совпадающих последовательностей. Эти результаты поддерживают возможность различия между стойким разрывом и завершённым мутагенным ремонтом, но не доказывают пользу такого вмешательства при старении. Источники: [Fumagalli et al., 2012](https://pmc.ncbi.nlm.nih.gov/articles/PMC3717580/), [Kent et al., 2015](https://www.nature.com/articles/nsmb.2961).
Молекулярная геронтология, учебный раздел «Геномная нестабильность и репарация ДНК при старении». Пересмотра потребует терапевтическая цель сохранения последовательности: для определённого класса стойких повреждений намеренная фиксация дополнительных ошибок окажется способом устойчивого продления жизни.
Старые мыши после короткого мутагенного ремонта живут дольше и медленнее теряют функции нескольких систем, хотя приобретают дополнительные соматические вставки и делеции. Эффект сохраняется после прекращения активности фермента и зависит от физического закрытия разрывов.
В выполненном целевом поиске не найден обзор, обосновывающий краткое усиление мутагенного соединения концов как способ длительного межсистемного улучшения и продления жизни при уже протекающем старении. Защитная роль ошибочного ремонта для выживания отдельных клеток известна. Поэтому радикальность относится именно к заявленному преимуществу для старого организма; абсолютная библиографическая новизна остаётся непроверенной.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.